Cargando…

Tackling Thyroid Cancer in Europe—The Challenges and Opportunities

Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an early stage that can benefit from effective interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Horgan, Denis, Führer-Sakel, Dagmar, Soares, Paula, Alvarez, Clara V., Fugazzola, Laura, Netea-Maier, Romana T., Jarzab, Barbara, Kozaric, Marta, Bartes, Beate, Schuster-Bruce, James, Dal Maso, Luigino, Schlumberger, Martin, Pacini, Furio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498891/
https://www.ncbi.nlm.nih.gov/pubmed/36141235
http://dx.doi.org/10.3390/healthcare10091621
_version_ 1784794873020284928
author Horgan, Denis
Führer-Sakel, Dagmar
Soares, Paula
Alvarez, Clara V.
Fugazzola, Laura
Netea-Maier, Romana T.
Jarzab, Barbara
Kozaric, Marta
Bartes, Beate
Schuster-Bruce, James
Dal Maso, Luigino
Schlumberger, Martin
Pacini, Furio
author_facet Horgan, Denis
Führer-Sakel, Dagmar
Soares, Paula
Alvarez, Clara V.
Fugazzola, Laura
Netea-Maier, Romana T.
Jarzab, Barbara
Kozaric, Marta
Bartes, Beate
Schuster-Bruce, James
Dal Maso, Luigino
Schlumberger, Martin
Pacini, Furio
author_sort Horgan, Denis
collection PubMed
description Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an early stage that can benefit from effective intervention, optimise therapy, and reduce the risk of overdiagnosis and unnecessary treatment. Questions remain about management, about treating all patients in referral centres, and about which treatment should be proposed to any individual patient and how this can be optimised. The European Alliance for Personalised Medicine (EAPM) hosted an expert panel discussion to elucidate some of the challenges, and to identify possible steps towards effective responses at the EU and member state level, particularly in the context of the opportunities in the European Union’s evolving initiatives—notably its Beating Cancer Plan, its Cancer Mission, and its research funding programmes. Recommendations emerging from the panel focus on improved infrastructure and funding, and on promoting multi-stakeholder collaboration between national and European initiatives to complement, support, and mutually reinforce efforts to improve patient care.
format Online
Article
Text
id pubmed-9498891
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94988912022-09-23 Tackling Thyroid Cancer in Europe—The Challenges and Opportunities Horgan, Denis Führer-Sakel, Dagmar Soares, Paula Alvarez, Clara V. Fugazzola, Laura Netea-Maier, Romana T. Jarzab, Barbara Kozaric, Marta Bartes, Beate Schuster-Bruce, James Dal Maso, Luigino Schlumberger, Martin Pacini, Furio Healthcare (Basel) Perspective Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an early stage that can benefit from effective intervention, optimise therapy, and reduce the risk of overdiagnosis and unnecessary treatment. Questions remain about management, about treating all patients in referral centres, and about which treatment should be proposed to any individual patient and how this can be optimised. The European Alliance for Personalised Medicine (EAPM) hosted an expert panel discussion to elucidate some of the challenges, and to identify possible steps towards effective responses at the EU and member state level, particularly in the context of the opportunities in the European Union’s evolving initiatives—notably its Beating Cancer Plan, its Cancer Mission, and its research funding programmes. Recommendations emerging from the panel focus on improved infrastructure and funding, and on promoting multi-stakeholder collaboration between national and European initiatives to complement, support, and mutually reinforce efforts to improve patient care. MDPI 2022-08-25 /pmc/articles/PMC9498891/ /pubmed/36141235 http://dx.doi.org/10.3390/healthcare10091621 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspective
Horgan, Denis
Führer-Sakel, Dagmar
Soares, Paula
Alvarez, Clara V.
Fugazzola, Laura
Netea-Maier, Romana T.
Jarzab, Barbara
Kozaric, Marta
Bartes, Beate
Schuster-Bruce, James
Dal Maso, Luigino
Schlumberger, Martin
Pacini, Furio
Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
title Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
title_full Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
title_fullStr Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
title_full_unstemmed Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
title_short Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
title_sort tackling thyroid cancer in europe—the challenges and opportunities
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498891/
https://www.ncbi.nlm.nih.gov/pubmed/36141235
http://dx.doi.org/10.3390/healthcare10091621
work_keys_str_mv AT horgandenis tacklingthyroidcancerineuropethechallengesandopportunities
AT fuhrersakeldagmar tacklingthyroidcancerineuropethechallengesandopportunities
AT soarespaula tacklingthyroidcancerineuropethechallengesandopportunities
AT alvarezclarav tacklingthyroidcancerineuropethechallengesandopportunities
AT fugazzolalaura tacklingthyroidcancerineuropethechallengesandopportunities
AT neteamaierromanat tacklingthyroidcancerineuropethechallengesandopportunities
AT jarzabbarbara tacklingthyroidcancerineuropethechallengesandopportunities
AT kozaricmarta tacklingthyroidcancerineuropethechallengesandopportunities
AT bartesbeate tacklingthyroidcancerineuropethechallengesandopportunities
AT schusterbrucejames tacklingthyroidcancerineuropethechallengesandopportunities
AT dalmasoluigino tacklingthyroidcancerineuropethechallengesandopportunities
AT schlumbergermartin tacklingthyroidcancerineuropethechallengesandopportunities
AT pacinifurio tacklingthyroidcancerineuropethechallengesandopportunities